secwatch.observer — SEC 8-K summary
======================================

Issuer:     SPRUCE BIOSCIENCES, INC. (SPRB)
CIK:        0001683553
Form:       8-K
Filed at:   2022-04-08T23:59:59+00:00
Accession:  0000950170-22-005528
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spruce Biosciences amends CEO Szwarcberg's equity vesting acceleration terms
----------------------------------------------------------------------------

- Amendment to CEO Javier Szwarcberg's offer letter dated April 6, 2022.
- Vesting acceleration under Severance Plan for Second Stock Option now only applies to Change in Control with effective date on or after January 3, 2023.
- All other terms and conditions of the offer letter remain unchanged.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1683553/000095017022005528/0000950170-22-005528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1683553/000095017022005528/sprb-20220406.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-005528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer